Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-γ

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Tietzel, Illya ^a   El Haibi, Christelle ^b   Carabeo, Rey A ^c  

^a UNIVERSITY OF NEW ORLEANS   (United States)

^b University of Louisville School of Medicine   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN 2; UNCLASSIFIED DRUG; PRIMER DNA; SMALL INTERFERING RNA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CELL INCLUSION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; FLUORESCENCE MICROSCOPY; GENE SILENCING; GROWTH, DEVELOPMENT AND AGING; HELA CELL; INTRACELLULAR MEMBRANE; METABOLISM; PATHOGENICITY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIAE; MURINAE;

BASE SEQUENCE; CHLAMYDIA TRACHOMATIS; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; INTERFERON-GAMMA; INTRACELLULAR MEMBRANES; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 68349127168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006499     Document Type: Article

References (45)

1. Perry LL, Su H, Feilzer K, Messer R, Hughes S, et al. (1999) Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 162: 3541-3548.
2. Su H, Messer R, Whitmire W, Hughes S, Caldwell HD (2000) Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect Immun 68: 192-196.
3. Yang X (2001) Distinct function of Th1 and Th2 type delayed type hypersensitivity: protective and pathological reactions to chlamydial infection. Microsc Res Tech 53: 273-277.
4. Wang S, Fan Y, Brunham RC, Yang X (1999) IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol 29: 3782-3792.
5. Byrne GI, Lehmann LK, Landry GJ (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittai replication in T24 cells. Infect Immun 53: 347-351.
6. Kane CD, Vena RM, Ouellette SP, Byrne GI (1999) Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells. Infect Immun 67: 1666-1671.
7. Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI (1994) Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 62: 3705-3711.
8. Thomas SM, Garrity LF, Brandt CR, Schobert CS, Feng GS, et al. (1993) IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol 150: 5529-5534.
9. Carlin JM, Borden EC, Byrne GI (1989) Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res 9: 329-337.
10. Byrne GI, Lehmann LK, Kirschbaum JG, Borden EC, Lee CM, et al. (1986) Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J Interferon Res 6: 389-396.
11. Brusic V, Pillai RS, Silva DG, Petrovsky N, Schonbach C (2003) Cytokine-related genes identified from the RIKEN full-length mouse cDNA data set. Genome Res 13: 1307-1317.
12. Schwemmle M, Kaspers B, Irion A, Staeheli P, Schultz U (1996) Chicken guanylate-binding protein. Conservation of GTPase activity and induction by cytokines. J Biol Chem 271: 10304-10308.
13. Lew DJ, Decker T, Strehlow I, Darnell JE (1991) Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol 11: 182-191.
14. Cheng YS, Becker-Manley MF, Rucker RG, Borden EC (1988) Accumulation of guanylate binding proteins in patients treated with interferons. J Interferon Res 8: 385-391.
15. Cheng YS, Colonno RJ, Yin FH (1983) Interferon induction of fibroblast proteins with guanylate binding activity. J Biol Chem 258: 7746-7750.
16. Strehlow I, Lohmann-Matthes ML, Decker T (1994) The interferon-inducible GBP1 gene: structure and mapping to human chromosome 1. Gene 144: 295-299.
17. Persano L, Moserle L, Esposito G, Bronte V, Barbieri V, et al. (2009) Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer. Carcinogenesis 30: 851-860.
18. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, et al. (2006) Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest 86: 997-1007.
19. Carter CC, Gorbacheva VY, Vestal DJ (2005) Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch Virol 150: 1213-1220.
20. Lubeseder-Martellato C, Guenzi E, Jorg A, Topolt K, Naschberger E, et al. (2002) Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol 161: 1749-1759.
21. Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, et al. (2001) The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. Embo J 20: 5568-5577.
22. Anderson SL, Carton JM, Lou J, Xing L, Rubin BY (1999) Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256: 8-14.
23. MacMicking JD (2004) IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 25: 601-609.
24. Cheng YS, Patterson CE, Staeheli P (1991) Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol Cell Biol 11: 4717-4725.
25. Cheng YS, Becker-Manley MF, Chow TP, Horan DC (1985) Affinity purification of an interferon-induced human guanylate-binding protein and its characterization. J Biol Chem 260: 15834-15839.
26. Modiano N, Lu YE, Cresswell P (2005) Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor. Proc Natl Acad Sci U S A 102: 8680-8685.
27. Miyairi I, Tatireddigari VR, Mahdi OS, Rose LA, Belland RJ, et al. (2007) The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol 179: 1814-1824.
28. Bernstein-Hanley I, Coers J, Balsara ZR, Taylor GA, Starnbach MN, et al. (2006) The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci U S A 103: 14092-14097.
29. Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, et al. (2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A 102: 10658-10663.
30. Coers J, Bernstein-Hanley I, Grotsky D, Parvanova I, Howard JC, et al. (2008) Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10. J Immunol 180: 6237-6245.
31. Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, et al. (2006) Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun 7: 122-129.
32. Al-Zeer MA, Al-Younes HM, Braun PR, Zerrahn J, Meyer TF (2009) IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS One 4: e4588.
33. Bekpen C, Marques-Bonet T, Alkan C, Antonacci F, Leogrande MB, et al. (2009) Death and resurrection of the human IRGM gene. PLoS Genet 5: e1000403.
34. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, et al. (2005) The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 6: R92.
35. Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS, Carabeo RA (2008) Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog 4: e1000014.
36. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C (2000) Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403: 567-571.
37. Perry LL, Feilzer K, Hughes S, Caldwell HD (1999) Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun 67: 1379-1385.
38. Perry LL, Feilzer K, Caldwell HD (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol 158: 3344-3352.
39. Paguirigan AM, Byrne GI, Becht S, Carlin JM (1994) Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect Immun 62: 1131-1136.
40. Ghosh A, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C (2006) How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. Nature 440: 101-104.
41. Singh SB, Davis AS, Taylor GA, Deretic V (2006) Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313: 1438-1441.
42. Deretic V, Singh S, Master S, Harris J, Roberts E, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8: 719-727.
43. Treadow BR, Khairallah EA (1972) Regulation of phospho-enol-pyruvate carboxykinase during starvation and glucose repression. Nat New Biol 239: 131-133.
44. Ballard FJ, Hopgood MF (1973) Phosphopyruvate carboxylase induction by L-tryptophan. Effects on synthesis and degradation of the enzyme. Biochem J 136: 259-264.
45. Sakurai T, Miyazawa S, Shindo Y, Hashimoto T (1974) The effect of tryptophan administration on fatty acid synthesis in the liver of the fasted normal rat. Biochim Biophys Acta 360: 275-288.